Literature DB >> 9209953

Pathological changes in pancreatic ducts from patients with chronic pancreatitis.

D E Bockman1, M Muller, M Büchler, H Friess, H G Beger.   

Abstract

CONCLUSION: Chronic pancreatitis and restricted pancreatic outflow are accompanied by pathological changes in the ducts, including inflammation and alterations in the microvasculature. These changes and loss of epithelium provide a likely explanation for increased release of serum proteins, immunoglobulins, and lactoferrin into the juice, and the possibility of luminal contents entering the extracellular space and bloodstream.
BACKGROUND: Enlargement of pancreatic ducts is a well-known phenomenon accompanying chronic pancreatitis and conditions restricting outflow of pancreatic juice. However, the relationship between ductal pathology and concomitant changes in the pancreatic juice is incompletely understood.
METHODS: Segments of pancreatic ducts removed at surgery from patients with chronic pancreatitis and conditions restricting outflow were studied by light and electron microscopy to assess the pathological changes.
RESULTS: Pathological changes in ducts from patients with chronic pancreatitis include chronic inflammation in the wall, enlarged and numerous capillaries packed with erythrocytes and leukocytes close to the lumen, and loss of epithelium and sometimes basement membrane. Plasma cells provide a source for increased immunoglobulins. Ducts from patients with diseases restricting outflow show significant pathology.

Entities:  

Mesh:

Year:  1997        PMID: 9209953     DOI: 10.1007/bf02822383

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  14 in total

1.  Letter: Immunoglobulin characterization.

Authors:  C Figarella; G W Brasher; W P Dyck; A M Spiekerman
Journal:  Am J Dig Dis       Date:  1976-01

2.  Immunocytochemical localization of lactoferrin in human neutrophils. An ultrastructural and morphometrical study.

Authors:  J Miyauchi; Y Watanabe
Journal:  Cell Tissue Res       Date:  1987-02       Impact factor: 5.249

3.  [Wirsung's duct of the normal pancreas and chronic pancreatitis. A study by scanning and transmission electronmicroscopy (author's transl)].

Authors:  P Lederer; M Stolte; H Tulusan
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-12-07

4.  [Albumin, IgG and IgA in normal adult human pancreatic juice].

Authors:  F Clemente; T Ribeiro; C Figarella; H Sarles
Journal:  Clin Chim Acta       Date:  1971-07       Impact factor: 3.786

5.  The pancreatic duct mucosal barrier.

Authors:  H A Reber; C Roberts; L W Way
Journal:  Am J Surg       Date:  1979-01       Impact factor: 2.565

6.  [Comparison of the proteins in pancreatic juice in normal and diseased humans. Determination of serum proteins and demonstration of a particular protein in chronic calcifying pancreatitis].

Authors:  F Clemente; T Ribeiro; E Colomb; C Figarella; H Sarles
Journal:  Biochim Biophys Acta       Date:  1971-12-28

7.  Immunoglobulin characterization of human pancreatic fluid.

Authors:  G W Brasher; W P Dyck; F F Hall; A M Spiekerman
Journal:  Am J Dig Dis       Date:  1975-05

8.  Pancreatic duct mucosa following bile salt injury in cats. Morphology, barrier function to pancreatic exocrine proteins and vulnerability by activated pancreatic juice.

Authors:  T Arendt; M Hänsler; G Appelt
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

9.  Alcohol and the integrity of the pancreas.

Authors:  D E Bockman; M Singh; R Laugier; H Sarles
Journal:  Scand J Gastroenterol Suppl       Date:  1985

10.  Lactoferrin, an iron-binding protein in neutrophilic leukocytes.

Authors:  P L Masson; J F Heremans; E Schonne
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

View more
  3 in total

1.  The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis.

Authors:  J Köninger; N A Giese; M Bartel; F F di Mola; P O Berberat; P di Sebastiano; T Giese; M W Büchler; H Friess
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Pancreatic Inflammation Redirects Acinar to β Cell Reprogramming.

Authors:  Hannah W Clayton; Anna B Osipovich; Jennifer S Stancill; Judsen D Schneider; Pedro G Vianna; Carolyn M Shanks; Weiping Yuan; Guoqiang Gu; Elisabetta Manduchi; Christian J Stoeckert; Mark A Magnuson
Journal:  Cell Rep       Date:  2016-11-15       Impact factor: 9.423

3.  BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.

Authors:  Hany Kayed; Sandor Bekasi; Shereen Keleg; Christoph W Michalski; Thomas Giese; Helmut Friess; Jörg Kleeff
Journal:  Mol Cancer       Date:  2007-12-28       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.